News | July 24, 2014

Texas Cardiac Arrhythmia Institute Among First in U.S. to Use Reveal Linq ICM

reveal linq, icm

Reveal Linq ICM

July 24, 2014 — Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center was among the first in the United States to implant the Medtronic Reveal Linq Insertable Cardiac Monitor (ICM) System in a patient. 
 
The Reveal Linq ICM is the smallest implantable cardiac monitoring device available. The procedure was performed by Andrea Natale, M.D., FHRS, FACC, FESC, cardiac electrophysiologist and executive medical director of TCAI. The Reveal Linq ICM is approximately one-third the size of a AAA battery, making it more than 80 percent smaller than other ICMs. 
 
While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient's heart for up to three years, with 20 percent more data memory than its larger predecessor, Reveal XT. 
 
"Every day, new technologies are paving the way for better outcomes and improved quality of life for cardiac patients," Natale said. "This new implantable device will not only allow us to more effectively monitor a patient's heart, but it will also improve the patient's experience. It can be worn for several years, and it goes virtually unnoticed." 
 
In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the Carelink Network. The Carelink Network allows physicians to request notifications that alert them if their patients have cardiac events. The Reveal Linq ICM is designed for patients who experience symptoms such as dizziness, palpitation, syncope and chest pain that may suggest a cardiac arrhythmia, as well as patients who are at an increased risk of cardiac arrhythmias. 
 
Placed just beneath the skin through a small incision of less than a centimeter in the upper-left side of the chest, the Reveal Linq ICM is nearly invisible to the naked eye once inserted. The device is placed using a minimally invasive insertion procedure, which simplifies the experience for both physicians and their patients. The Reveal Linq ICM is MR-Conditional, allowing patients to undergo magnetic resonance imaging (MRI) if needed.
 
The Reveal Linq system also includes the new MyCareLink Patient Monitor, a simplified remote monitoring system with global cellular technology that transmits patients' cardiac device diagnostic data to their clinicians from almost any location in the world. 
 
For more information: www.medtronic.com/patients/fainting/device/our-insertable-cardiac-monitors/reveal-linq-icm/

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Overlay Init